- Home
- CUE vs INFU Comparison
CUE vs INFU Comparison
Compare CUE & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | INFU |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.0M | 197.0M |
| IPO Year | 2017 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CUE | INFU |
|---|---|---|
| Price | $27.77 | $13.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $88.00 | $16.83 |
| AVG Volume (30 Days) | ★ 373.8K | 117.1K |
| Earning Date | 11-11-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.11 | ★ 181.82 |
| EPS | N/A | ★ 0.20 |
| Revenue | $27,466,000.00 | ★ $143,436,000.00 |
| Revenue This Year | N/A | $1.20 |
| Revenue Next Year | N/A | $6.16 |
| P/E Ratio | ★ N/A | $67.05 |
| Revenue Growth | ★ 195.75 | 6.36 |
| 52 Week Low | $0.17 | $7.29 |
| 52 Week High | $45.50 | $13.85 |
Technical Indicators
Market Signals| Indicator | CUE | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 68.46 |
| Support Level | $24.27 | $8.59 |
| Resistance Level | $33.11 | N/A |
| Average True Range (ATR) | 3.36 | 0.40 |
| MACD | -0.54 | 0.02 |
| Stochastic Oscillator | 43.15 | 77.24 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.